Drug shortage
Carbamazepine Capsule · Takeda Pharmaceuticals USA Inc.
FDA drug shortage · To Be Discontinued · updated Dec 19, 2025
Key facts
| Generic name | Carbamazepine Capsule, Extended Release |
|---|---|
| Company | Takeda Pharmaceuticals USA Inc. |
| Presentation | Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12) |
| Dosage form | Capsule, Extended Release |
| Status | To Be Discontinued |
| Therapeutic category | Neurology |
| Package NDCs | 54092-171-12 |
| First posted | Dec 19, 2025 |
| Last updated | Dec 19, 2025 |
| Discontinued | Dec 19, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: